Eversept Partners as of June 30, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 73 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Quality Care Properties | 11.0 | $23M | 1.1M | 21.51 | |
R1 Rcm | 7.5 | $16M | 1.8M | 8.68 | |
Aerie Pharmaceuticals | 7.3 | $15M | 227k | 67.55 | |
Radius Health | 6.6 | $14M | 469k | 29.47 | |
GlaxoSmithKline | 4.9 | $10M | 253k | 40.84 | |
Sanofi-Aventis SA (SNY) | 4.1 | $8.5M | 213k | 40.01 | |
BioMarin Pharmaceutical (BMRN) | 3.8 | $7.9M | 84k | 94.20 | |
Teligent | 3.5 | $7.3M | 2.1M | 3.46 | |
Sage Therapeutics (SAGE) | 3.2 | $6.8M | 43k | 156.54 | |
Zogenix | 3.2 | $6.7M | 151k | 44.20 | |
Alnylam Pharmaceuticals (ALNY) | 3.0 | $6.3M | 64k | 98.48 | |
Ensign (ENSG) | 2.8 | $6.0M | 166k | 35.86 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.8 | $5.9M | 35k | 169.95 | |
Arena Pharmaceuticals | 2.8 | $5.8M | 134k | 43.60 | |
Sarepta Therapeutics (SRPT) | 2.5 | $5.3M | 40k | 132.18 | |
Nevro (NVRO) | 1.8 | $3.8M | 47k | 79.85 | |
Spdr S&p 500 Etf Tr option | 1.8 | $3.7M | 300.00 | 12320.00 | |
Abbott Laboratories (ABT) | 1.3 | $2.8M | 46k | 60.98 | |
athenahealth | 1.2 | $2.5M | 16k | 159.12 | |
Tesaro | 1.1 | $2.3M | 53k | 44.48 | |
Anaptysbio Inc Common (ANAB) | 1.1 | $2.3M | 33k | 71.03 | |
Abiomed | 1.1 | $2.3M | 5.6k | 409.01 | |
Apellis Pharmaceuticals (APLS) | 1.0 | $2.2M | 98k | 22.00 | |
ArQule | 1.0 | $2.1M | 374k | 5.53 | |
Argenx Se (ARGX) | 1.0 | $2.0M | 24k | 82.84 | |
Ascendis Pharma A S (ASND) | 0.9 | $2.0M | 30k | 66.51 | |
Invacare Corporation | 0.9 | $1.9M | 100k | 18.60 | |
Caretrust Reit (CTRE) | 0.8 | $1.7M | 101k | 16.90 | |
Medicines Company | 0.7 | $1.4M | 39k | 36.70 | |
Cymabay Therapeutics | 0.7 | $1.4M | 107k | 13.42 | |
Amarin Corporation (AMRN) | 0.7 | $1.4M | 460k | 3.09 | |
Puma Biotechnology (PBYI) | 0.7 | $1.4M | 24k | 59.15 | |
Tandem Diabetes Care (TNDM) | 0.6 | $1.3M | 61k | 22.02 | |
Haemonetics Corporation (HAE) | 0.6 | $1.3M | 15k | 89.65 | |
Immunomedics | 0.6 | $1.3M | 55k | 23.67 | |
Myokardia | 0.6 | $1.3M | 26k | 49.63 | |
eHealth (EHTH) | 0.6 | $1.3M | 57k | 22.11 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $1.3M | 4.5k | 279.78 | |
Anthem (ELV) | 0.6 | $1.2M | 5.0k | 238.00 | |
Zogenix Inc put | 0.6 | $1.2M | 1.2k | 974.05 | |
Akorn | 0.6 | $1.2M | 70k | 16.59 | |
Tg Therapeutics (TGTX) | 0.5 | $1.1M | 80k | 13.15 | |
Dicerna Pharmaceuticals | 0.5 | $1.0M | 85k | 12.25 | |
Centene Corporation (CNC) | 0.5 | $986k | 8.0k | 123.25 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $854k | 149k | 5.73 | |
Cellectis S A (CLLS) | 0.4 | $849k | 30k | 28.30 | |
Array BioPharma | 0.4 | $812k | 48k | 16.77 | |
Vericel (VCEL) | 0.3 | $726k | 75k | 9.70 | |
Arbutus Biopharma (ABUS) | 0.3 | $712k | 98k | 7.30 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $704k | 55k | 12.80 | |
Epizyme | 0.3 | $643k | 47k | 13.55 | |
Albireo Pharma | 0.3 | $640k | 18k | 35.50 | |
Affimed Therapeutics B V | 0.3 | $638k | 387k | 1.65 | |
Global Blood Therapeutics In | 0.3 | $624k | 14k | 45.22 | |
Foamix Pharmaceuticals | 0.3 | $539k | 108k | 5.01 | |
IntriCon Corporation | 0.2 | $484k | 12k | 40.33 | |
Melinta Therapeutics | 0.2 | $488k | 77k | 6.35 | |
Model N (MODN) | 0.2 | $418k | 23k | 18.61 | |
Dynavax Technologies (DVAX) | 0.2 | $412k | 27k | 15.26 | |
Ophthotech | 0.2 | $407k | 149k | 2.73 | |
Seaspine Holdings | 0.2 | $390k | 31k | 12.62 | |
Peregrine Pharmaceuticals (CDMO) | 0.2 | $394k | 100k | 3.92 | |
Celyad Sa | 0.2 | $382k | 13k | 29.75 | |
Quality Care Pptys Inc call | 0.2 | $387k | 200.00 | 1935.00 | |
Deciphera Pharmaceuticals (DCPH) | 0.2 | $375k | 9.5k | 39.32 | |
Iradimed (IRMD) | 0.2 | $365k | 18k | 20.73 | |
Magellan Health Services | 0.1 | $288k | 3.0k | 96.00 | |
Dermira | 0.1 | $184k | 20k | 9.19 | |
Zogenix Inc call | 0.1 | $199k | 100.00 | 1990.00 | |
Conformis | 0.1 | $159k | 127k | 1.25 | |
Galmed Pharmaceuticals | 0.1 | $119k | 10k | 11.90 | |
Quality Care Pptys Inc put | 0.0 | $12k | 18.00 | 666.67 | |
Celgene Corp right 12/31/2011 | 0.0 | $2.0k | 6.0k | 0.33 |